+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liver Disease Drug"

Global Liver Disease Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Liver Disease Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 191 Pages
  • Global
From
Liver Disease Treatment Market by Treatment Type and Disease Type: Global Opportunity Analysis and Industry Forecast, 2021-2030 - Product Thumbnail Image

Liver Disease Treatment Market by Treatment Type and Disease Type: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • Report
  • December 2021
  • 254 Pages
  • Global
From
North America Liver Disease Treatment Market by Treatment Type and Disease Type: Opportunity Analysis and Industry Forecast, 2020-2027 - Product Thumbnail Image

North America Liver Disease Treatment Market by Treatment Type and Disease Type: Opportunity Analysis and Industry Forecast, 2020-2027

  • Report
  • September 2020
  • 137 Pages
  • North America
From
Loading Indicator

The Liver Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat a variety of liver diseases, including hepatitis, cirrhosis, and fatty liver disease. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Commonly used drugs include antivirals, immunosuppressants, and antifibrotics. In addition, some drugs are used to reduce the risk of liver cancer. The Liver Disease Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. Other companies include Bristol-Myers Squibb, AstraZeneca, and Roche. Show Less Read more